FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Michael Muders

Research Profile

Chemicals & Drugs

Disorders

Procedures

Concepts & Ideas

Anatomy

Living Beings

Inbred DBA Mouse

Co-author Network

Publications

TOP 3
A Singer; Michael Muders; D Pfitzmann; A Rentsch; G B Baretton; Michael Baumann; Y Deuse; S Hehlgans; Tobias Hoelscher; C Jakob; U Koch; Mechthild Krause
Impact of the adaptor protein GIPC1/Synectin on radioresistance and survival after irradiation of prostate cancer.
Y Mueller-Koch; Holger Vogelsang; Reinhard Kopp; Peter Lohse; Gisela Keller; Daniela E Aust; Michael Muders; Manfred Gross; J Daum; Uwe Schiemann; Monika Grabowski; M Scholz; Brigitte Kerker; I Becker; Gaby Henke; Elke Holinski-Feder
Hereditary non-polyposis colorectal cancer: clinical and molecular evidence for a new entity of hereditary colorectal cancer.
Uwe Schiemann; Yvonne Müller-Koch; Manfred Gross; Jürgen Glas; Gustavo B Baretton; Michael Muders; Thomas Mussack; Elke Holinski-Feder
Detection of occult high graded microsatellite instabilities in MMR gene mutation negative HNPCC tumors by addition of complementary marker analysis.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Michael Muders (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: A Singer; Michael Muders; D Pfitzmann; A Rentsch; G B Baretton; Michael Baumann; Y Deuse; S Hehlgans; Tobias Hoelscher; C Jakob; U Koch; Mechthild Krause
Impact of the adaptor protein GIPC1/Synectin on radioresistance and survival after irradiation of prostate cancer.
Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al] 2012;188(12):1125-32.
2005: Y Mueller-Koch; Holger Vogelsang; Reinhard Kopp; Peter Lohse; Gisela Keller; Daniela E Aust; Michael Muders; Manfred Gross; J Daum; Uwe Schiemann; Monika Grabowski; M Scholz; Brigitte Kerker; I Becker; Gaby Henke; Elke Holinski-Feder
Hereditary non-polyposis colorectal cancer: clinical and molecular evidence for a new entity of hereditary colorectal cancer.
Gut 2005;54(12):1733-40.
2005: Uwe Schiemann; Yvonne Müller-Koch; Manfred Gross; Jürgen Glas; Gustavo B Baretton; Michael Muders; Thomas Mussack; Elke Holinski-Feder
Detection of occult high graded microsatellite instabilities in MMR gene mutation negative HNPCC tumors by addition of complementary marker analysis.
European journal of medical research 2005;10(1):23-8.
2005: Uwe Schiemann; Silke Günther; Manfred Gross; Gaby Henke; Yvonne Müller-Koch; August König; Michael Muders; Christian Folwaczny; Thomas Mussack; Elke Holinski-Feder
Preoperative serum levels of the carcinoembryonic antigen in hereditary non-polyposis colorectal cancer compared to levels in sporadic colorectal cancer.
Cancer detection and prevention 2005;29(4):356-60.
2004: Daniela E Aust; Michael Muders; A Köhler; M Schmidt; Joachim Diebold; C Müller; Udo Löhrs; Frederic M Waldman; Gustavo B Baretton
Prognostic relevance of 20q13 gains in sporadic colorectal cancers: a FISH analysis.
Scandinavian journal of gastroenterology 2004;39(8):766-72.
2004: Konstantin Nikolaou; Hans-Christoph Becker; Michael Muders; Gregor Babaryka; Juergen Scheidler; Thomas Flohr; Udo Loehrs; Maximilian F Reiser; zahi Fayad
Multidetector-row computed tomography and magnetic resonance imaging of atherosclerotic lesions in human ex vivo coronary arteries.
Atherosclerosis 2004;174(2):243-52.
2004: Josef Rüschoff; B Roggendorf; Frank Brasch; Micaela Mathiak; Daniela E Aust; Jens Plaschke; W Mueller; Christopher Poremba; Matthias Kloor; G Keller; Michael Muders; S Blasenbreu-Vogt; Petra Rümmele; A Müller; Reinhard Büttner
[Molecular pathology in hereditary colorectal cancer. Recommendations of the Collaborative German Study Group on hereditary colorectal cancer funded by the German Cancer Aid (Deutsche Krebshilfe)].
Der Pathologe 2004;25(3):178-92.
2004: Alexander Meining; T Rösch; Ralf Kiesslich; Michael Muders; F Sax; Walter Heldwein
Inter- and intra-observer variability of magnification chromoendoscopy for detecting specialized intestinal metaplasia at the gastroesophageal junction.
Endoscopy 2004;36(2):160-4.
2004: Uwe Schiemann; Yvonne Müller-Koch; Manfred Gross; J Daum; Peter Lohse; Gustavo B Baretton; Michael Muders; Thomas Mussack; Reinhard Kopp; Elke Holinski-Feder
Extended microsatellite analysis in microsatellite stable, MSH2 and MLH1 mutation-negative HNPCC patients: genetic reclassification and correlation with clinical features.
Digestion 2004;69(3):166-76.
2003: Hans-Christoph Becker; Konstantin Nikolaou; Michael Muders; Gregor Babaryka; Alexander Crispin; Uwe O.P. Joseph Schoepf; Udo Loehrs; Maximilian F Reiser
Ex vivo coronary atherosclerotic plaque characterization with multi-detector-row CT.
European radiology 2003;13(9):2094-8.
2003: Michael Muders; Kamran Ghoreschi; M Suckfuell; W Zimmermann; G Enders
Studies on the immunogenicity of hCEA in a transgenic mouse model.
International journal of colorectal disease 2003;18(2):153-9.
2003: Reinhard Kopp; Elisabeth Rothbauer; Maximilian Ruge; Hans Arnholdt; Joachim Spranger; Michael Muders; Doris G Pfeiffer; Friedrich W Schildberg; Andreas Pfeiffer
Clinical implications of the EGF receptor/ligand system for tumor progression and survival in gastrointestinal carcinomas: evidence for new therapeutic options.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 2003;162():115-32.
1998: Kamran Ghoreschi; Michael Muders; Georg A Enders
Functional role of CD95 ligand in concanavalin A-induced intestinal intraepithelial lymphocyte cytotoxicity.
Immunology 1998;95(4):566-71.